CD markers in pituitary adenomas

ISSN： 1046-3976

Source： Endocrine Pathology, Vol.12, Iss.3, 2001-09, pp. : 307-313

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

VEGF and CD31 Association in Pituitary Adenomas

By Cristina Carolina Perez-Millan María Luque Guillermina Dulce Raúl Sevlever Gustavo Berner Silvia Becu-Villalobos Damasia

Endocrine Pathology, Vol. 21, Iss. 3, 2010-09 ,pp. : 154-160

Humana Press, Inc

Access to resources Recommend Favorite

Characterization of C-Kit (CD117) Expression in Human Normal Pituitary Cells and Pituitary Adenomas

By La Rosa Stefano Uccella Silvia Dainese Linda Marchet Silvia Placidi Claudia Vigetti Davide Capella Carlo

Endocrine Pathology, Vol. 19, Iss. 2, 2008-06 ,pp. : 104-111

Humana Press, Inc

Access to resources Recommend Favorite

The History of the Treatment of Pituitary Adenomas

By Maartens Nicholas F.

Endocrine Journal, Vol. 28, Iss. 1, 2005-10 ,pp. : 9-26

Humana Press, Inc

Access to resources Recommend Favorite

Stereotactic Radiosurgery for Pituitary Adenomas

By Marcou Y. Plowman P.N.

Trends in Endocrinology and Metabolism, Vol. 11, Iss. 4, 2000-05 ,pp. : 132-137

Elsevier

Access to resources Recommend Favorite

Ghrelin immunoexpression in pituitary adenomas

By Rotondo Fabio

Pituitary, Vol. 14, Iss. 4, 2011-12 ,pp. : 318-322

Springer Publishing Company

Access to resources Recommend Favorite